4
Changes in Ownership
LISATA THERAPEUTICS, INC. Filed Acc 0001144204-12-025083
Options or other derivatives
- Chief Financial Officer acquired 56,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
May Larry Alan · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2012-04-26 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +56,250 | $0.36 | 2022-04-25 | 56,520 | 56,250 | D |
Loading xslF345X03/v311243_4.xml…